You just read:

Arena Pharmaceuticals Reports Positive Phase 2a Results for Olorinab in Patients with Abdominal Pain Associated with Crohn's Disease

News provided by

Arena Pharmaceuticals, Inc.

Sep 24, 2018, 16:01 ET